Stock Market & Financial Investment News

News Breaks December 13, 2012 09:17 EDT SRPT Sarepta Therapeutics 4.95M share Spot Secondary priced at $25.25 The deal priced at the high end of the $25.00-$25.25 range and was increased to $125M in common stock. Lazard Capital acted as sole book running manager for the offering. News For SRPT From The Last 14 Days Check below for free stories on SRPT the last two weeks. Sign up for a free trial to see the rest of the stories you've been missing. May 16, 2013 07:29 EDT SRPT Leerink to host a bus tour Boston Biopharma Bus Tour travels throughout Boston on May 16-17. May 9, 2013 12:21 EDT SRPT Sarepta climbs after saying documents to be submitted this month Subscribe for More Information 07:29 EDT SRPT Sarepta reports Q1 EPS (41c), consensus (62c) Reports Q1 revenue $4.5M, consensus $5.85M. May 7, 2013 13:15 EDT SRPT Options with increasing implied volatility: CVRR SRPT PGH TWO GDI HNZ Subscribe for More Information 08:59 EDT SRPT Sarepta initiates dosing in Phase I study of Marburg virus treatment Subscribe for More Information Sign up for a free trial to see the rest of the stories you've been missing.